Literature DB >> 18428191

Development of retention prediction models for adrenoreceptor agonists and antagonists on a polyvinyl alcohol-bonded stationary phase in hydrophilic interaction chromatography.

Noel S Quiming1, Nerissa L Denola, Shahril Reza Bin Samsuri, Yoshihiro Saito, Kiyokatsu Jinno.   

Abstract

Retention prediction models based on multiple linear regression (MLR) and artificial neural network (ANN) for adrenoreceptor agonists and antagonists chromatographed on a polyvinyl alcohol-bonded stationary phase under hydrophilic interaction chromatography were described. The models showed the combined effects of solute structure and mobile phase composition on the retention behavior of the analytes. Using stepwise MLR, the retentions of the studied compounds were satisfactorily described by a five-predictor model; the predictors being the %ACN, the logarithm of the partition coefficient (log D), the number of hydrogen bond donors (HBD), the desolvation energy for octanol (FOct), and the total absolute atomic charge (TAAC). The inclusion of the solute-related descriptors suggested that hydrophilic interactions such as hydrogen bonding and also ionic interactions are possible mechanisms by which analytes are retained on the studied system. ANN prediction models were also derived using the predictors derived from MLR as inputs and log k as outputs. The best network architectures were found to be 5-3-1 for the datasets at pH 3.0 and 4.0, and 5-4-1 for the dataset at pH 5.0. The optimized ANNs showed better predictive properties than the MLR models for both training and test sets under all pH conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18428191     DOI: 10.1002/jssc.200700598

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  1 in total

1.  Chromatographic separation of glycated peptide isomers derived from glucose and fructose.

Authors:  Sebastian Schmutzler; Ralf Hoffmann
Journal:  Anal Bioanal Chem       Date:  2022-08-03       Impact factor: 4.478

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.